The fact
Tested on melanoma patients, it triggers a targeted immune response.
Researchers plan a Phase III trial to confirm its effectiveness.
8 sources — click a link to read an article on the topic:
Tested on melanoma patients, it triggers a targeted immune response.
Researchers plan a Phase III trial to confirm its effectiveness.